3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Infections
1
Bone Neoplasms
1
Interventions
Itraconazole
2
liposomal amphotericin B
1
Voriconazole
1
Vancomycin
1
Valacyclovir
1
Therapeutics
1
Tazobactam
1
Ribavirin
1
Polymerase Chain Reaction
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Pentetic Acid
1
Palivizumab
1
Negative-Pressure Wound Therapy
1
Minocycline
1
Mannose-Binding Lectin
1
Immunologic Techniques
1
Heparin
1
Fluconazole
1
Flow Cytometry
1
Cefazolin
1
Caspofungin
1
Acyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Cefazolin
×
Sarcoma
×
Clear all
NCT01479283
2021-03-11
PARITY
McMaster University
Phase 3
Completed
602 enrolled